miR-632 Functions as Oncogene in Hepatocellular Carcinoma via Targeting MYCT1.

Q1 Medicine
Human Gene Therapy Clinical Development Pub Date : 2019-06-01 Epub Date: 2019-05-08 DOI:10.1089/humc.2019.040
Jian Pu, Jianchu Wang, Zuoming Xu, Yuan Lu, Xianjian Wu, Yi Wu, Zesheng Shao, Qianli Tang, Huamei Wei
{"title":"miR-632 Functions as Oncogene in Hepatocellular Carcinoma via Targeting MYCT1.","authors":"Jian Pu,&nbsp;Jianchu Wang,&nbsp;Zuoming Xu,&nbsp;Yuan Lu,&nbsp;Xianjian Wu,&nbsp;Yi Wu,&nbsp;Zesheng Shao,&nbsp;Qianli Tang,&nbsp;Huamei Wei","doi":"10.1089/humc.2019.040","DOIUrl":null,"url":null,"abstract":"<p><p>microRNAs (miRNAs) have been widely recognized as crucial regulators for tumorigenesis. However, the role of miR-632 in hepatocellular carcinoma (HCC) remains largely unknown. miR-632 expression in HCC cell lines was determined by quantitative real-time polymerase chain reaction. The role of miR-632 expression on overall survival of HCC patients was examined on the Kaplan-Meier plotter Web site. The dual luciferase reporter method was performed to investigate whether myc target 1 (MYCT1) was a target of miR-632. Cell counting kit-8 assay, colony formation assay, and Transwell invasion assay were performed to examine cell proliferation, colony formation, and cell invasion of HCC cells. The results showed miR-632 expression was elevated in HCC cell lines compared to normal cell lines. Loss-of-function experiments demonstrated that miR-632 downregulation was able to inhibit HCC cell proliferation, colony formation, and cell invasion. Moreover, miR-632 could negatively regulate the expression of MYCT1 in HCC cells. Importantly, the study showed miR-632 and MYCT1 were negatively correlated by analyzing the public data sets obtained from the Gene Expression Omnibus. Knockdown of MYCT1 by small interfering RNA partially reversed the effects of miR-632 on HCC cell events. The present study suggests that miR-632 regulates growth and invasion of HCC cells through targeting MYCT1.</p>","PeriodicalId":51315,"journal":{"name":"Human Gene Therapy Clinical Development","volume":"30 2","pages":"67-73"},"PeriodicalIF":0.0000,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/humc.2019.040","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Gene Therapy Clinical Development","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/humc.2019.040","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/5/8 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 11

Abstract

microRNAs (miRNAs) have been widely recognized as crucial regulators for tumorigenesis. However, the role of miR-632 in hepatocellular carcinoma (HCC) remains largely unknown. miR-632 expression in HCC cell lines was determined by quantitative real-time polymerase chain reaction. The role of miR-632 expression on overall survival of HCC patients was examined on the Kaplan-Meier plotter Web site. The dual luciferase reporter method was performed to investigate whether myc target 1 (MYCT1) was a target of miR-632. Cell counting kit-8 assay, colony formation assay, and Transwell invasion assay were performed to examine cell proliferation, colony formation, and cell invasion of HCC cells. The results showed miR-632 expression was elevated in HCC cell lines compared to normal cell lines. Loss-of-function experiments demonstrated that miR-632 downregulation was able to inhibit HCC cell proliferation, colony formation, and cell invasion. Moreover, miR-632 could negatively regulate the expression of MYCT1 in HCC cells. Importantly, the study showed miR-632 and MYCT1 were negatively correlated by analyzing the public data sets obtained from the Gene Expression Omnibus. Knockdown of MYCT1 by small interfering RNA partially reversed the effects of miR-632 on HCC cell events. The present study suggests that miR-632 regulates growth and invasion of HCC cells through targeting MYCT1.

miR-632通过靶向MYCT1在肝细胞癌中起癌基因作用
microRNAs (miRNAs)已被广泛认为是肿瘤发生的关键调节因子。然而,miR-632在肝细胞癌(HCC)中的作用在很大程度上仍然未知。通过实时定量聚合酶链反应检测miR-632在HCC细胞系中的表达。在Kaplan-Meier绘图仪网站上检测了miR-632表达对HCC患者总生存率的作用。采用双荧光素酶报告方法研究myc靶标1 (MYCT1)是否是miR-632的靶标。采用细胞计数试剂盒-8法、集落形成法和Transwell侵袭法检测细胞增殖、集落形成和细胞侵袭。结果显示,与正常细胞系相比,miR-632在HCC细胞系中的表达升高。功能缺失实验表明,miR-632下调能够抑制HCC细胞增殖、集落形成和细胞侵袭。此外,miR-632可以负向调节MYCT1在HCC细胞中的表达。重要的是,该研究通过分析从基因表达Omnibus获得的公共数据集显示miR-632和MYCT1呈负相关。通过小干扰RNA敲低MYCT1部分逆转了miR-632对HCC细胞事件的影响。本研究提示miR-632通过靶向MYCT1调控HCC细胞的生长和侵袭。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Human Gene Therapy Clinical Development
Human Gene Therapy Clinical Development CRITICAL CARE MEDICINEMEDICINE, RESEARCH &-MEDICINE, RESEARCH & EXPERIMENTAL
CiteScore
7.20
自引率
0.00%
发文量
0
期刊介绍: Human Gene Therapy (HGT) is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes important advances in DNA, RNA, cell and immune therapies, validating the latest advances in research and new technologies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信